These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33368608)

  • 1. Increased frequency of heart transplantation, shortened waitlist time and preserved post-transplant survival in adults with congenital heart disease, on the new heart transplant allocation system.
    Jani M; Cook S; Huang SH; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2021 Apr; 35(4):e14205. PubMed ID: 33368608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system.
    Gonzalez MH; Acharya D; Lee S; Leacche M; Boeve T; Manandhar-Shrestha N; Jovinge S; Loyaga-Rendon RY
    J Heart Lung Transplant; 2021 Feb; 40(2):149-157. PubMed ID: 33277169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased frequency of transplantation and lower post-transplant survival free of re-transplantation in LVAD patients with the new heart transplant allocation system.
    Jani M; Lee S; Acharya D; Hoeksema S; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2022 Jan; 36(1):e14493. PubMed ID: 34689383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the 2018 change in US allocation policy on adults with congenital heart disease.
    Ashraf SF; Hess N; Seese L; Kavarana MN; Tedford RJ; Rajab TK; Kilic A
    J Heart Lung Transplant; 2022 Mar; 41(3):373-381. PubMed ID: 34906403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage.
    Patel JN; Abramov D; Fudim M; Okwuosa IS; Rabkin DG; Chung JS
    Clin Transplant; 2022 May; 36(5):e14620. PubMed ID: 35213753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Outcomes of Heart Transplantation in Adults With Congenital Heart Disease Receiving Regionalized Care.
    Nguyen VP; Dolgner SJ; Dardas TF; Verrier ED; McMullan DM; Krieger EV
    J Am Coll Cardiol; 2019 Dec; 74(23):2908-2918. PubMed ID: 31806135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system.
    Kainuma A; Ning Y; Kurlansky PA; Wang AS; Axom K; Farr M; Sayer G; Uriel N; Naka Y; Takeda K
    Clin Transplant; 2021 Nov; 35(11):e14458. PubMed ID: 34398487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Opportunities for Transplantation for Women in the New Heart Allocation System.
    Defilippis EM; Truby LK; Clerkin KJ; Donald E; Sinnenberg L; Varshney AS; Cogswell R; Kittleson MM; Haythe JH; Givertz MM; Hsich EM; Agarwal R; Topkara VK; Farr M
    J Card Fail; 2022 Jul; 28(7):1149-1157. PubMed ID: 35470056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised Heart Allocation Policy Improved Waitlist Mortality and Waiting Time With Maintained Outcomes in En-Bloc Heart-Lung Transplant Candidates and Recipients.
    Shudo Y; He H; Elde S; Woo YJ
    Transpl Int; 2023; 36():11956. PubMed ID: 38152546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-Level Variation in Waitlist Mortality and Transplant Outcomes Among Patients Listed for Heart Transplantation in the US From 2011 to 2016.
    Akintoye E; Shin D; Alvarez P; Briasoulis A
    JAMA Netw Open; 2020 Dec; 3(12):e2028459. PubMed ID: 33295970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved waitlist and comparable post-transplant outcomes in simultaneous heart-kidney transplantation under the 2018 heart allocation system.
    Hong Y; Hess NR; Ziegler LA; Hickey GW; Huston JH; Mathier MA; McNamara DM; Keebler ME; Gómez H; Kaczorowski DJ
    J Thorac Cardiovasc Surg; 2024 Mar; 167(3):1064-1076.e2. PubMed ID: 37480982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of recipient BMI on waitlist and post-transplant outcomes after the 2018 heart transplant allocation policy change.
    Patel JN; Rabkin DG; Sperry BW; Bhardwaj A; Chung JS; Abramov D
    J Card Surg; 2022 Jul; 37(7):1896-1904. PubMed ID: 35384068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.
    Krishnamurthy Y; Cooper LB; Lu D; Schroder JN; Daneshmand MA; Rogers JG; Milano CA; Hernandez AF; Patel CB
    J Heart Lung Transplant; 2016 May; 35(5):619-24. PubMed ID: 26856668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive strategy in donor acceptance: Impact on pediatric waitlist and heart transplant outcomes.
    Baez Hernandez N; Kirk R; Davies R; Bano M; Sutcliffe D; Pirolli T; Jaquiss R; Daneman S; Butts RJ
    Pediatr Transplant; 2020 Sep; 24(6):e13764. PubMed ID: 32536034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States.
    Cevasco M; Shin M; Cohen W; Helmers MR; Weingarten N; Rekhtman D; Wald JW; Iyengar A
    Clin Transplant; 2023 Oct; 37(10):e15066. PubMed ID: 37392194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased disparities in waitlist and post-heart transplantation outcomes according to socioeconomic status with the new heart transplant allocation system.
    Kelty CE; Dickinson MG; Leacche M; Jani M; Shrestha NK; Lee S; Acharya D; Rajapreyar I; Sadler RC; McNeely E; Loyaga-Rendon RY
    J Heart Lung Transplant; 2024 Jan; 43(1):134-147. PubMed ID: 37643656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy.
    Fowler CC; Helmers MR; Smood B; Iyengar A; Patrick W; Alan Herbst D; Altshuler P; Han JJ; Kelly J; Atluri P
    J Heart Lung Transplant; 2021 Oct; 40(10):1181-1190. PubMed ID: 34332861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in heart transplant waitlist and posttransplant outcomes in patients with restrictive and hypertrophic cardiomyopathy with the new heart transplant allocation system.
    Loyaga-Rendon RY; Fermin D; Jani M; Gonzalez M; Grayburn R; Lee S; Dickinson MG; Manandhar-Shrestha NK; Boeve T; Jovinge S; Leacche M
    Am J Transplant; 2021 Mar; 21(3):1255-1262. PubMed ID: 32978873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis.
    Jawitz OK; Fudim M; Raman V; Bryner BS; DeVore AD; Mentz RJ; Milano C; Patel CB; Schroder JN; Rogers JG
    JACC Heart Fail; 2020 Jul; 8(7):548-556. PubMed ID: 32417413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.